UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liver fibrosis: Common mechanisms and antifibrotic therapies

Clinics and research in hepatology and gastroenterology, 2015-09, Vol.39, p.S51-S59

Schuppan, Detlef

2015

Volltextzugriff (PDF)

Determinants of fibrosis progression and regression in NASH

Journal of hepatology, 2018-02, Vol.68 (2), p.238-250

2018

Volltextzugriff (PDF)

Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

Hepatology (Baltimore, Md.), 2009-10, Vol.50 (4), p.1294-1306

2009

Volltextzugriff (PDF)

Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers

Cells (Basel, Switzerland), 2020-09, Vol.9 (9), p.2027

2020

Volltextzugriff (PDF)

Liver fibrosis: Direct antifibrotic agents and targeted therapies

Matrix biology, 2018-08, Vol.68-69, p.435-451

2018

Volltextzugriff (PDF)

Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment

Journal of hepatology, 2013-05, Vol.58 (5), p.1028-1041

2013

Volltextzugriff (PDF)

Celiac Disease: From Pathogenesis to Novel Therapies

Gastroenterology (New York, N.Y. 1943), 2009-12, Vol.137 (6), p.1912-1933

2009

Volltextzugriff (PDF)

Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches

Journal of gastroenterology and hepatology, 2013-08, Vol.28 (S1), p.68-76

2013

Volltextzugriff (PDF)

Liver cirrhosis

The Lancet (British edition), 2008-03, Vol.371 (9615), p.838-851

2008

Volltextzugriff (PDF)

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Nature reviews. Gastroenterology & hepatology, 2019-03, Vol.16 (3), p.145-159

2019

Volltextzugriff (PDF)

Anti-fibrotic therapy: Lost in translation?

Journal of hepatology, 2012, Vol.56, p.S66-S74

2012

Volltextzugriff (PDF)

The enemy within the gut: bacterial pathogens in celiac autoimmunity

Nature structural & molecular biology, 2020-01, Vol.27 (1), p.5-7

2020

Volltextzugriff (PDF)

Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Cells (Basel, Switzerland), 2020-09, Vol.9 (9), p.2102

2020

Volltextzugriff (PDF)

Kommentar zu: Multiple Nahrungsmittelallergien: Omalizumab erhöht Reaktionsschwellen

Gastroenterologie up2date, 2024-09, Vol.20 (3), p.217-218

Schuppan, Detlef

2024

Volltextzugriff (PDF)

Macrophages and platelets in liver fibrosis and hepatocellular carcinoma

Frontiers in immunology, 2023-12, Vol.14, p.1277808-1277808

2023

Volltextzugriff (PDF)

Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4

The Journal of experimental medicine, 2012-12, Vol.209 (13), p.2395-2408

2012

Volltextzugriff (PDF)

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

The FASEB journal, 2016-04, Vol.30 (4), p.1599-1609

2016

Volltextzugriff (PDF)

Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets

Gastroenterology (New York, N.Y. 1943), 2014-11, Vol.147 (5), p.1073-1083.e6

2014

Volltextzugriff (PDF)

Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis

Hepatology (Baltimore, Md.), 2015-10, Vol.62 (4), p.1285-1297

2015

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.1339-1350.e1

2014

Volltextzugriff (PDF)

Gluten Degrading Enzymes for Treatment of Celiac Disease

Nutrients, 2020-07, Vol.12 (7), p.2095

2020

Volltextzugriff (PDF)

Effects of nintedanib on the microvascular architecture in a lung fibrosis model

Angiogenesis (London), 2017-08, Vol.20 (3), p.359-372

2017

Volltextzugriff (PDF)

Collagen biology and non‐invasive biomarkers of liver fibrosis

Liver international, 2020-04, Vol.40 (4), p.736-750

2020

Volltextzugriff (PDF)

Air Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants

Environmental science & technology, 2017-04, Vol.51 (8), p.4119-4141

2017

Volltextzugriff (PDF)

Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients

Gastroenterology (New York, N.Y. 1943), 2016-09, Vol.151 (3), p.513-525.e0

2016

Volltextzugriff (PDF)

1 – 25 von 836

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(759)
Mit Volltextzugriff
(754)

Publikationsform

Sprache

Englisch
(796)
Deutsch
(39)
Spanisch
(1)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(461)
Life Sciences & Biomedicine
(441)
Humans
(326)
Gastroenterology & Hepatology
(225)
Animals
(184)
Male
(163)
Female
(135)
Biological And Medical Sciences
(134)
Medical Sciences
(124)
Gastroenterology And Hepatology
(108)
Fibrosis
(98)
Middle Aged
(95)
Mice
(92)
Adult
(84)
Gastroenterology. Liver. Pancreas. Abdomen
(78)
Celiac Disease
(65)
Rats
(63)
Liver - Pathology
(62)
Collagen
(59)
Gluten
(58)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Liver fibrosis: Common mechanisms and antifibrotic therapies

Determinants of fibrosis progression and regression in NASH

Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers

Liver fibrosis: Direct antifibrotic agents and targeted therapies

Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment

Celiac Disease: From Pathogenesis to Novel Therapies

Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches

Liver cirrhosis

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Anti-fibrotic therapy: Lost in translation?

The enemy within the gut: bacterial pathogens in celiac autoimmunity

Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Kommentar zu: Multiple Nahrungsmittelallergien: Omalizumab erhöht Reaktionsschwellen

Macrophages and platelets in liver fibrosis and hepatocellular carcinoma

Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets

Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis

Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice

Gluten Degrading Enzymes for Treatment of Celiac Disease

Effects of nintedanib on the microvascular architecture in a lung fibrosis model

Collagen biology and non‐invasive biomarkers of liver fibrosis

Air Pollution and Climate Change Effects on Allergies in the Anthropocene: Abundance, Interaction, and Modification of Allergens and Adjuvants

Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients

Suchergebnisse filtern